Skip to main content
FibroGen, Inc. (FGEN)
NASDAQ: FGEN · Real-Time Price · USD
0.400
+0.046 (13.09%)
Dec 20, 2024, 4:00 PM EST - Market closed

FibroGen Revenue

FibroGen had revenue of $46.33M in the quarter ending September 30, 2024, with 15.45% growth. This brings the company's revenue in the last twelve months to $180.02M, up 16.15% year-over-year. In the year 2023, FibroGen had annual revenue of $147.75M with 4.99% growth.

Revenue (ttm)
$180.02M
Revenue Growth
+16.15%
P/S Ratio
0.22
Revenue / Employee
$370,401
Employees
486
Market Cap
40.31M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023147.75M7.02M4.99%
Dec 31, 2022140.73M-94.58M-40.19%
Dec 31, 2021235.31M58.99M33.46%
Dec 31, 2020176.32M-80.26M-31.28%
Dec 31, 2019256.58M43.62M20.48%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
DIH Holding US 73.49M
Enzo Biochem 30.31M
CASI Pharmaceuticals 22.06M
Daxor 154.21K
Actinium Pharmaceuticals 81.00K
Revenue Rankings

FGEN News

More News